CT Clinical Research

Cromwell, Connecticut 06416

2 studies enrolling now · 14 studies all time

What they study most

Acute Migraine, Acute Treatment of Migraine, Adjunctive Treatment of Major Depressive Disorder, Alzheimer Disease, Attention-Deficit/Hyperactivity Disorder, Binge Eating Disorder, Depressive Disorder, Major, Migraine, Pediatric Migraine, Post Traumatic Stress Disorder, Schizophrenia

Studies at this site

• Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine — Recruiting now
• Randomized Study in Children and Adolescents With Migraine: Acute Treatment — Recruiting now
• A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine — Completed
• A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia — Running, not enrolling
• A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine — Completed
• Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease — Completed
• A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression — Completed
• A Study of JZP150 in Adults With Posttraumatic Stress Disorder — Completed
• Acute Treatment Trial in Adult Subjects With Migraines — Completed
• Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) — Stopped early
• Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine — Completed
• Randomized Trial in Adult Participants With Acute Migraines — Completed
• Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment — Completed
• Dasotraline Binge Eating Disorder Extension Study — Completed